Insights
Search Results
Client Highlights
11.02.26
Firm Advises Marvell on $115 Billion Acquisition of Lumentum
On November 2, 2026, Marvell Technology, a leader in data infrastructure semiconductor solutions, announced that they have entered into a definitive agreement to acquire Lumentum, a global leader in optical and photonic technologies that power the networks and infrastructure behind artificial intelligence, cloud computing, and next-generation communications, in an all-stock transaction. Under the terms of the agreement, Lumentum stockholders will receive a fixed exchange ratio of 4.500 shares of Marvell common stock for each share of Lumentum common stock they own. The transaction has an implied enterprise value of $115 billion for Lumentum, representing approximately $1,132 per share of Lumentum common stock and a premium of approximately 23.9 percent based on each company’s unaffected closing share price as of October 28, 2026. Wilson Sonsini Goodrich & Rosati is advising Marvell on the transaction.
Client Highlights
10.16.26
Wilson Sonsini Advises Amaero on IPO
On October 14, 2026, Amaero, a leading U.S.-based producer of high-value refractory and titanium alloy spherical metal powders for additive manufacturing (AM) and advanced manufacturing, and a pioneer in Powder Metallurgy Hot Isostatic Pressing (PM-HIP) manufacturing of large near-net-shape components, announced the pricing of its initial public offering of 4,705,883 shares of its common stock at a price of $4.25 per share. Amaero has also granted the underwriters a 30-day option to purchase up to an additional 705,882 shares of its common stock at the initial public offering price, less underwriting discounts and commissions. Wilson Sonsini Goodrich & Rosati advised Amaero on the transaction.
Client Highlights
10.01.26
Wilson Sonsini Advises Stripe on Acquisition of Parafin
On September 30, 2026, Stripe, the programmable financial services company, announced that it has agreed to acquire Parafin, a leading embedded financial products platform. Wilson Sonsini Goodrich & Rosati is advising Stripe on the transaction.
Client Highlights
9.29.26
Wilson Sonsini Advises World Labs on $8.2 Billion Acquisition by AMD
On September 28, 2026, AMD, a global semiconductor company, announced it has entered into a definitive agreement to acquire World Labs, an AI model and research lab led by AI pioneer Dr. Fei-Fei Li. The acquisition will bring a world-class team of researchers and model experts to AMD, strengthening its ability to develop AI hardware, software, and systems. Wilson Sonsini Goodrich & Rosati is advising World Labs on the transaction.
Client Highlights
9.15.26
Wilson Sonsini Advises DoorDash on $300 Million Acquisition of Wonder’s Grubhub Campus Dining Business
On September 15, 2026, DoorDash, a global leader in local commerce, and Wonder, a leading food technology platform, announced that DoorDash will acquire Wonder's Grubhub Campus Dining business for $300 million. Wilson Sonsini Goodrich & Rosati advised DoorDash on the transaction.
Grubhub Campus Dining, formerly known as Tapingo, enables millions of students at more than 450 colleges and universities to order a meal from campus dining facilities and on-campus restaurants using its mobile app or kiosks, pay for the meal with campus dining dollars, and schedule the pickup. Following the close of the transaction, DoorDash intends to continue expanding Grubhub Campus Dining in the U.S., enhance the selection and convenience available to students, and bring Tapingo’s vertically integrated technology stack beyond college campuses to stadiums, hotels, and other similar venues.
The Wilson Sonsini team that advised DoorDash on the transaction was led by partners Rezwan Pavri, Lang Liu, Sachin Kohli, and Brendan Mahan and associates Ryan Cooper and Jackie Jung. The team also included:
Grubhub Campus Dining, formerly known as Tapingo, enables millions of students at more than 450 colleges and universities to order a meal from campus dining facilities and on-campus restaurants using its mobile app or kiosks, pay for the meal with campus dining dollars, and schedule the pickup. Following the close of the transaction, DoorDash intends to continue expanding Grubhub Campus Dining in the U.S., enhance the selection and convenience available to students, and bring Tapingo’s vertically integrated technology stack beyond college campuses to stadiums, hotels, and other similar venues.
The Wilson Sonsini team that advised DoorDash on the transaction was led by partners Rezwan Pavri, Lang Liu, Sachin Kohli, and Brendan Mahan and associates Ryan Cooper and Jackie Jung. The team also included:
Client Highlights
9.03.26
Wilson Sonsini Advises Hugging Face on $12.9 Billion Acquisition by NVIDIA
On September 3, 2026, NVIDIA announced that it has agreed to acquire open-source AI platform Hugging Face for $12.9 billion. Together, NVIDIA and Hugging Face plan to scale Hugging Face’s platform, strengthen its infrastructure, and expand access to AI for developers and institutions worldwide. Wilson Sonsini Goodrich & Rosati advised Hugging Face on the transaction.
Client Highlights
8.26.26
Wilson Sonsini Advises Altruist on Acquisition by Vanguard
On August 26, 2026, Vanguard and Altruist, an AI-forward wealth technology and custody platform serving financial advisors, announced that they have entered into a definitive agreement under which Vanguard will acquire Altruist. Wilson Sonsini Goodrich & Rosati is advising Altruist on the transaction.
Client Highlights
8.20.26
Wilson Sonsini Advises Highspot on Merger with Seismic
On August 18, 2026, Seismic, an AI-powered sales and revenue enablement platform, announced the completion of its merger with Highspot. Following a second request review, the merger obtained U.S. antitrust clearance, which allowed the transaction to close without any action by the Department of Justice Antitrust Division. The combined company will operate under the Seismic name and be led by Seismic Chief Executive Officer Rob Tarkoff. Wilson Sonsini Goodrich & Rosati advised Highspot on the transaction.
News Articles
8.13.26
Brandon Gantus Discusses 280G "Golden Parachute" Tax Rules with The Circle
"Section 280G: The 'Golden Parachute' Tax Rules Every Executive Should Understand," an article published by The Circle by Founders Circle Capital based on an interview with Wilson Sonsini partner Brandon Gantus, explains Section 280G "golden parachute" tax rules and their impact on M&A deals.
Client Highlights
8.03.26
Wilson Sonsini Advises Firefly Bio on $1 Billion Acquisition by Johnson & Johnson
On July 29, 2026, Johnson & Johnson announced the completion of its acquisition of Firefly Bio, a biotechnology company advancing its proprietary Firelink™ degrader antibody conjugate platform, for $1 billion in cash. The Firelink™ DAC platform expands Johnson & Johnson’s oncology portfolio and advances the company’s ambition to develop targeted therapies for some of the most prevalent and difficult-to-treat solid tumors, including KRAS-driven cancers. Wilson Sonsini Goodrich & Rosati advised Firefly Bio on the transaction.
Client Highlights
7.29.26
Wilson Sonsini Advises DroneDeploy on $845 Million Acquisition by Procore Technologies
On July 29, 2026, Procore Technologies, a global provider of construction management software, announced it has entered into a definitive agreement to acquire DroneDeploy, a robotics and visual intelligence platform. Procore will acquire DroneDeploy for approximately $845 million in cash, subject to customary purchase price adjustments. Wilson Sonsini Goodrich & Rosati is advising DroneDeploy on the transaction
Client Highlights
7.27.26
Firm Advises Forte Biosciences on $2.2 Billion Acquisition by argenx
On July 27, 2026, argenx, a global immunology innovation company, and Forte Biosciences, a clinical-stage biopharmaceutical company, announced that they have entered into a definitive agreement under which argenx will acquire Forte Biosciences for $77.00 per share in cash, representing a total equity value of approximately $2.2 billion. FB102, Forte Biosciences’ lead program, expands argenx’s portfolio of differentiated immunology medicines, adding a first-in-class anti-CD122 antibody with clinical proof-of-concept in vitiligo and celiac disease and potential to address multiple autoimmune diseases. Wilson Sonsini Goodrich & Rosati advised Forte Biosciences on the transaction.